Vanguard Group
ITCI

Vanguard Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,519,968
Closed -$1.26B 4364
2025
Q1
$1.26B Sell
9,519,968
-201,392
-2% -$26.6M 0.02% 576
2024
Q4
$812M Buy
9,721,360
+93,107
+1% +$7.78M 0.01% 781
2024
Q3
$704M Buy
9,628,253
+21,347
+0.2% +$1.56M 0.01% 837
2024
Q2
$658M Buy
9,606,906
+380,925
+4% +$26.1M 0.01% 824
2024
Q1
$638M Buy
9,225,981
+131,679
+1% +$9.11M 0.01% 869
2023
Q4
$651M Buy
9,094,302
+554,577
+6% +$39.7M 0.01% 828
2023
Q3
$445M Buy
8,539,725
+43,689
+0.5% +$2.28M 0.01% 953
2023
Q2
$538M Buy
8,496,036
+52,879
+0.6% +$3.35M 0.01% 882
2023
Q1
$457M Buy
8,443,157
+123,908
+1% +$6.71M 0.01% 957
2022
Q4
$440M Buy
8,319,249
+203,229
+3% +$10.8M 0.01% 955
2022
Q3
$378M Buy
8,116,020
+35,822
+0.4% +$1.67M 0.01% 1000
2022
Q2
$461M Buy
8,080,198
+291,729
+4% +$16.7M 0.01% 909
2022
Q1
$477M Buy
7,788,469
+912,268
+13% +$55.8M 0.01% 1001
2021
Q4
$360M Sell
6,876,201
-15,368
-0.2% -$804K 0.01% 1213
2021
Q3
$257M Buy
6,891,569
+63,132
+0.9% +$2.35M 0.01% 1441
2021
Q2
$279M Buy
6,828,437
+106,744
+2% +$4.36M 0.01% 1415
2021
Q1
$228M Buy
6,721,693
+240,349
+4% +$8.16M 0.01% 1518
2020
Q4
$206M Buy
6,481,344
+252,046
+4% +$8.02M 0.01% 1449
2020
Q3
$160M Buy
6,229,298
+958,854
+18% +$24.6M 0.01% 1412
2020
Q2
$135M Buy
5,270,444
+10,614
+0.2% +$272K ﹤0.01% 1512
2020
Q1
$80.8M Buy
5,259,830
+1,040,240
+25% +$16M ﹤0.01% 1647
2019
Q4
$145M Buy
4,219,590
+37,460
+0.9% +$1.29M ﹤0.01% 1567
2019
Q3
$31.2M Sell
4,182,130
-8,051
-0.2% -$60.1K ﹤0.01% 2278
2019
Q2
$54.4M Sell
4,190,181
-26,354
-0.6% -$342K ﹤0.01% 2059
2019
Q1
$51.4M Buy
4,216,535
+282,605
+7% +$3.44M ﹤0.01% 2072
2018
Q4
$44.8M Sell
3,933,930
-9,862
-0.3% -$112K ﹤0.01% 2081
2018
Q3
$85.6M Buy
3,943,792
+69,950
+2% +$1.52M ﹤0.01% 1880
2018
Q2
$68.5M Buy
3,873,842
+135,165
+4% +$2.39M ﹤0.01% 1963
2018
Q1
$78.7M Buy
3,738,677
+8,419
+0.2% +$177K ﹤0.01% 1844
2017
Q4
$54M Buy
3,730,258
+264,005
+8% +$3.82M ﹤0.01% 2024
2017
Q3
$54.7M Buy
3,466,253
+744,521
+27% +$11.7M ﹤0.01% 1993
2017
Q2
$33.8M Sell
2,721,732
-20,155
-0.7% -$250K ﹤0.01% 2217
2017
Q1
$44.6M Buy
2,741,887
+186,165
+7% +$3.03M ﹤0.01% 2064
2016
Q4
$38.6M Buy
2,555,722
+96,351
+4% +$1.45M ﹤0.01% 2102
2016
Q3
$37.5M Buy
2,459,371
+103,658
+4% +$1.58M ﹤0.01% 2068
2016
Q2
$91.4M Buy
2,355,713
+781,550
+50% +$30.3M 0.01% 1576
2016
Q1
$43.8M Buy
1,574,163
+174,451
+12% +$4.85M ﹤0.01% 1925
2015
Q4
$75.3M Buy
1,399,712
+438,581
+46% +$23.6M 0.01% 1664
2015
Q3
$38.5M Buy
961,131
+237,138
+33% +$9.5M ﹤0.01% 1994
2015
Q2
$23.1M Buy
723,993
+94,118
+15% +$3.01M ﹤0.01% 2290
2015
Q1
$15M Buy
629,875
+180,872
+40% +$4.32M ﹤0.01% 2451
2014
Q4
$7.93M Buy
449,003
+44,095
+11% +$778K ﹤0.01% 2649
2014
Q3
$5.55M Buy
404,908
+9,976
+3% +$137K ﹤0.01% 2767
2014
Q2
$6.66M Buy
394,932
+57,292
+17% +$966K ﹤0.01% 2700
2014
Q1
$6.14M Buy
+337,640
New +$6.14M ﹤0.01% 2727